Ahmed A. Al‐Karmalawy

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor

Ahmed A. Al‐Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly et al. · Frontiers in Chemistry · 2021 · 261 citations · Full text

Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors

Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa et al. · Archiv der Pharmazie · 2019 · 148 citations

Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and <i>in vitro</i> insights

Dalia Elebeedy, Walid F. Elkhatib, Ahmed Kandeil et al. · RSC Advances · 2021 · 118 citations · Full text

Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: <i>In Vitro</i> and Molecular Docking Studies

Shenouda G. Eliaa, Ahmed A. Al‐Karmalawy, Rasha M. Saleh et al. · ACS Pharmacology & Translational Science · 2020 · 115 citations · Full text

Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations

Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa et al. · Archiv der Pharmazie · 2019 · 111 citations